SSG
USNA icon

Summit Securities Group’s Usana Health Sciences USNA Stock Holding History

Summit Securities Group’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-49,600
Closed -$3.17M – 331
2015
Q4 		$3.17M Buy
+49,600
New +$3.22M 1.02% 19
2014
Q2 		– Sell
-148
Closed -$6K – 655
2014
Q1 		$6K Buy
+148
New +$5.17K ﹤0.01% 304
2013
Q3 		– Sell
-200
Closed -$7K – 556
2013
Q2 		$7K Buy
+200
New +$6.08K ﹤0.01% 359

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return

Summit Securities Group's USNA Position: Q1 2016 in Review

Summit Securities Group sold out of Usana Health Sciences (USNA) in Q1 2016, closing a stake of 49,600 shares — an estimated $3.17M sold.

Summit Securities Group first reported a position in USNA in Q2 2013 and held it in 3 quarters. The position peaked at $3.17M in Q4 2015. 136 funds tracked by Wall St. Rank hold USNA as of Q1 2016.

  • Summit Securities Group reported no remaining Usana Health Sciences position as of Q1 2016 after selling out during the quarter.
  • Summit Securities Group sold 49,600 Usana Health Sciences shares in Q1 2016, an estimated $3.17M.
  • Summit Securities Group first reported a position in Usana Health Sciences in Q2 2013 and held it in 3 quarters.
  • Summit Securities Group's Usana Health Sciences position peaked at $3.17M in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2016.

Based on Summit Securities Group's 13F filing for Q1 2016, filed 11 May 2016.